company background image
1B1 logo

HC Surgical Specialists Catalist:1B1 Stock Report

Last Price

S$0.27

Market Cap

S$40.8m

7D

-1.9%

1Y

-32.9%

Updated

15 Jul, 2024

Data

Company Financials

HC Surgical Specialists Limited

Catalist:1B1 Stock Report

Market Cap: S$40.8m

HC Surgical Specialists Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HC Surgical Specialists
Historical stock prices
Current Share PriceS$0.27
52 Week HighS$0.42
52 Week LowS$0.24
Beta0.073
11 Month Change-7.02%
3 Month Change0%
1 Year Change-32.91%
33 Year Change-44.79%
5 Year Change-52.68%
Change since IPO-51.82%

Recent News & Updates

Recent updates

Shareholder Returns

1B1SG HealthcareSG Market
7D-1.9%2.7%2.5%
1Y-32.9%-19.2%2.2%

Return vs Industry: 1B1 underperformed the SG Healthcare industry which returned -19.2% over the past year.

Return vs Market: 1B1 underperformed the SG Market which returned 2.2% over the past year.

Price Volatility

Is 1B1's price volatile compared to industry and market?
1B1 volatility
1B1 Average Weekly Movement8.0%
Healthcare Industry Average Movement4.9%
Market Average Movement4.7%
10% most volatile stocks in SG Market13.2%
10% least volatile stocks in SG Market2.1%

Stable Share Price: 1B1 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1B1's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of SG stocks.

About the Company

FoundedEmployeesCEOWebsite
2015n/aSieu Min Heahwww.hcsurgicalspecialists.com

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal abscesses, anal fissures, anal fistula, gallstones and inflammation of the gallbladder, appendicitis, hernias, gastric and colorectal cancer, colonic diverticular disease, and cysts and lipomas; vein laser vascular, laparoscopy, cholecystitis, and other general and specialized medical services; and orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, carpel tunnel syndrome, wounds/lumps, joint replacement, arthroscopic surgery, and fractures.

HC Surgical Specialists Limited Fundamentals Summary

How do HC Surgical Specialists's earnings and revenue compare to its market cap?
1B1 fundamental statistics
Market capS$40.76m
Earnings (TTM)S$4.32m
Revenue (TTM)S$18.91m

9.4x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1B1 income statement (TTM)
RevenueS$18.91m
Cost of RevenueS$9.60m
Gross ProfitS$9.30m
Other ExpensesS$4.98m
EarningsS$4.32m

Last Reported Earnings

Nov 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.028
Gross Margin49.20%
Net Profit Margin22.85%
Debt/Equity Ratio12.2%

How did 1B1 perform over the long term?

See historical performance and comparison

Dividends

5.3%

Current Dividend Yield

59%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.